A rare cause of hyperamylasemia: multiple myeloma

Gülden Sincan 1 , Yusuf Bilen 1 , Fuat Erdem 1  and Mehmet Gündoğdu 1
  • 1 Atatürk University, School Of Medicine, Departments Of Hematology, Erzurum, Turkey
Gülden Sincan, Yusuf Bilen, Fuat Erdem and Mehmet Gündoğdu

Abstract

Background:

A higher amylase than normal concentration may reflect one of several medical conditions, including acute inflammation of the pancreas, perforated peptic ulcer, torsion of an ovarian cyst, strangulation ileus, mesenteric ischemia, macroamylasemia, renal failure and mumps. In addition; amylase production by epithelial carcinomas has been well documented. But hyperamylasemia associated with multiple myeloma has been reported only in a few cases. We report a case with hyperamylasemia associated with multiple myeloma in this paper because of rarity.

Case report:

We report a 64 year old male patient with multiple myeloma. He had hyperamylasemia and no evidence of pancreatic and salivary gland disease, renal failure. The patient had relapse disease after autologous bone marrow transplant. Amylase value is high correlated with his disease status. Combined chemotherapy (lenalidomide 25 mg once daily orally on days 1–21 and dexamethosone 40 mg/day, days 1–4 of repeated 28-day cycles) was started to our patient for multiple myeloma. The amylase level decresed to a normal level after 28 days.

Conclusion:

Paraneoplastic hyperamylasaemia as a marker to monitor disease progression and treatment response in cases with multiple myeloma. It related to extensive extra-medullary spread, extensive bone destruction and shorter survival time.

  • 1.

    Hata H, Matsuzaki H, Tanaka K, Nomura H, Kagimoto T, Takeya M, et al. Ectopic production of salivary type amylase by a IgA- λ -type multiple myeloma. Cancer 1988;62:1511–15.

    • Crossref
    • PubMed
    • Export Citation
  • 2.

    Kim SY, Kim JH, Kim CH, Nam SW, Kim YJ, Kim JI, et al. A case of pheochromocytoma with hyperamylasaemia. Korean J Gastroenterol 2003;42:172–75.

  • 3.

    Crook M. Hyperamylasaemia: don’t forget undiagnosed carcinoma. Ann Clin Biochem 2013;51:5–7.

    • PubMed
    • Export Citation
  • 4.

    Pinelli M, Bindi M, Rosada J, Scatena P, Castiglioni M. Amylase: a disease activity index in multiple myeloma? Leukemia-Lymphoma 2006;47:151–54.

    • Crossref
    • PubMed
    • Export Citation
  • 5.

    Bloemendal HJ, Lobatto S. Hyperamylasaemia in multiple myeloma. Neth J Med 1996;49:38–41.

    • Crossref
    • PubMed
    • Export Citation
  • 6.

    Nair S, Sachan P, Hertan H, Pitchumoni CS. Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia. Postgrad Med J 1998;74:621–23.

    • Crossref
    • PubMed
    • Export Citation
  • 7.

    Ross CM, Devgun MS, Gunn IR. Hyperamylasaemia and multiple myeloma. Ann Clin Biochem 2002;39:616–20.

    • Crossref
    • PubMed
    • Export Citation
  • 8.

    Calvo-Villas JM, Alvarez I, Carretera E, Espinosa J, Sicilia F. Paraneoplastic hyperamylasemia in association with multiple myeloma. Acta Haematol 2007;117:242–45.

    • Crossref
    • PubMed
    • Export Citation
  • 9.

    Yamakawa T, Nagoshi H, Takahashi A, Fukumura R, Takahashi S, Nomura M, et al. Acquired amylase production induced by radiotherapy in a myeloma patient. Rinsho Ketsueki 1995;36:1175–81.

Purchase article
Get instant unlimited access to the article.
$42.00
Log in
Already have access? Please log in.


or
Log in with your institution

Journal + Issues

Turkish Journal of Biochemistry (TJB), official journal of Turkish Biochemical Society, is issued electronically every 2 months. The main aim of the journal is to support the research and publishing culture by ensuring that every published manuscript has an added value and thus providing international acceptance of the “readability” of the manuscripts published in the journal.

Search